2017 ASH Advocacy Activities
Published on: November 29, 2017
advocacy, there is strength in numbers, so ASH is continuing to increase its
efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access
to drugs, and sickle cell disease remain top priorities on ASH’s advocacy
agenda in 2017. More than ever, ASH
needs help from its members to educate Congress, federal officials, and the
public, on these (and other) issues.